combination

The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids. Part 3 of 3

Posted on by TraciKaufman

The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids – Part 3 of 3

In the backer trial, funded by the Health Research Council of New Zealand, Beasley’s team randomly assigned 303 patients to the single-inhaler protocol or to usual care with two inhalers. Over six months, the researchers found that those using Symbicort had fewer grim asthma attacks. One concern had been that patients using the combination inhaler would get overexposed to corticosteroid or would overuse the inhaler stretcher.

They found, however, that patients using the bloc inhaler reduced their overuse of corticosteroid by 40 percent, compared to those using separate inhalers. While those in the SMART program took in more corticosteroids a day, they had fewer asthma attacks so their overall view to corticosteroid was the same as for people in the two-inhaler group, the New Zealand researchers explained.

Parts: 1 2 3

The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids. Part 2 of 3

Posted on by TraciKaufman

The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids – Part 2 of 3

In the United States, use of these combination inhalers is also not considered first-line therapy for asthma, according to Dr Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City. “Patients, however, are currently using these trust inhalers”. If the asthma is moderate to severe, then a combination inhaler is appropriate who was not involved with either new study.

patients

The reports were published in the March matter of the journal Lancet Respiratory Medicine. One study was funded by Italian pharmaceutical company Chiesi Farmaceutici, whose products include asthma medications. The multi-center European den was led by Dr Klaus Rabe, a professor of pulmonary medicine at the University of Kiel, in Germany.

The study included more than 1700 patients with moderate asthma. Researchers found that participants using the single, society inhaler had significantly fewer severe asthma attacks and were seen at a hospital or urgent medical facility less than those patients using the two inhalers. Rabe and colleagues wrote that although drugs like Symbicort (the limited budesonide/formoterol combination used in the study) can be more expensive than separate inhalers, the ability to prevent asthma attacks and reduce hospital and emergency room visits may be cost-saving in the end.

Parts: 1 2 3

The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids. Part 1 of 3

Posted on by TraciKaufman

The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids – Part 1 of 3

The Combination Of The Two Inhalers For Asthma Greatly Reduces The Use Of Corticosteroids. Asthma patients typically use two inhaled drugs – one a fast-acting “rescue inhaler” to shoot attacks and another long-lasting one to anticipate them. However, combining both in one inhaler may be best for some patients, two new studies suggest. Patients with deliberate to severe asthma who used a combination inhaler had fewer attacks than those on two separate inhalers, researchers report. Both studies tested the so-called SMART (single maintenance and reliever therapy) protocol. “The SMART discipline was more effective as a treatment for asthma than the conventional treatment, where you just use a inhaler at a fixed maintenance dose and a short-acting inhaler for the relief of symptoms,” said Dr Richard Beasley, vice-president of the Medical Research Institute of New Zealand in Wellington and lead researcher of one of the studies.

These drugs are a combination of a corticosteroid (such as budesonide or fluticasone) and a long-acting beta-2 agonist (such as salmeterol or formoterol) and are sold under various disgrace names including Seretide, Symbicort and Advair. In asthma, treatment increases as the severity of the condition does. So, this party therapy isn’t the first choice.

When the asthma is difficult to control with other methods, “we are now recommending the SMART regime. You treat the patients according to their needs. This is certainly not what you start them on – it is something you would use on referee to severe patients”.

Parts: 1 2 3

Doctors Recommend A New Complex Cancer Treatment. Part 3 of 3

Posted on by TraciKaufman

Doctors Recommend A New Complex Cancer Treatment – Part 3 of 3

Anthracyclines are remarkable in treating HER2-positive breast cancer, but have very toxic side effects that can lead to congestive heart failure and leukemia. Doctors found that 92 percent of 3,231 women treated with the unexplored combination chemo survived more than three years with no recurrence of their cancer. These results make the new combination a viable alternative to anthracycline-based chemotherapy, said hero researcher Dr Dennis Slamon, director of clinical-translational research at the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles.

So “It is going to be difficult to arise treatment regimens that have even better response rates than that,” said Slamon, who is also chief of hematology-oncology with UCLA’s department of medicine This study was supported by funds from Roche/Genentech. Slamon has served as an counsel to both companies, including during the time period when the study was conducted mamu ne bhanji ko choda pakstani story. Because the studies were presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

Parts: 1 2 3

Doctors Recommend A New Complex Cancer Treatment. Part 2 of 3

Posted on by TraciKaufman

Doctors Recommend A New Complex Cancer Treatment – Part 2 of 3

Piccart-Gebhart reported that 84 percent of the patients who received the combination targeted therapy between 2008 and 2010 have remained cancer-free, compared with 76 percent who only received Herceptin. “It’s too advanced today to say this dual treatment saves more lives. We can’t say that on the basis of this trial”. The drawbacks of this combination therapy are cost and side effects, Piccart-Gebhart said.

combination

Targeted therapies outlay tens of thousands of dollars, and combining the two drugs increases toxic side effects such as diarrhea and rash. “There is a price to pay in terms of attitude effects. There will be a price to pay in terms of drug costs”. This study was supported by funds from GlaxoSmithKline. Piccart-Gebhart has received honoraria from Roche, and her institution has received on funding from GlaxoSmithKline.

The second study involved 156 patients who received chemotherapy and Herceptin before surgery. However, this study focused on the levels of immune cells called lymphocytes that had infiltrated the heart tumors. For every 10 percent increase in the levels of tumor-infiltrating lymphocytes, there was a 16 percent increase in the number of patients whose breast tumors were eradicated, said lead researcher Dr Sherene Loi. Loi is a medical oncologist and leadership of the translational breast cancer genomics lab at the Peter MacCallum Cancer Center in Melbourne, Australia.

She said Herceptin might be convenient to activate the immune cells. However, her team found that not all women have high levels of these immune cells in their tumors. “Previously, breast cancer has not thought to be suitable for immunotherapy approaches. Our results outfit evidence that this could be a new strategy for treatment in breast cancer”. The third study compared the effectiveness of a combination chemotherapy using the drugs docetaxel and carboplatin against traditional chemotherapy with medications called anthracyclines.

Parts: 1 2 3

Doctors Recommend A New Complex Cancer Treatment. Part 1 of 3

Posted on by TraciKaufman

Doctors Recommend A New Complex Cancer Treatment – Part 1 of 3

Doctors Recommend A New Complex Cancer Treatment. Women with bellicose breast cancer who receive combination targeted therapy with chemotherapy prior to surgery have a somewhat improved chance of staying cancer-free, researchers say. However, the improvement was not statistically significant and the jury is still out on combination treatment, said lead researcher Dr Martine Piccart-Gebhart, chair of the Breast International Group, in Brussels. “I don’t expect that tomorrow we should switch to a new standard of care.

Piccart-Gebhart presented her findings Wednesday at the 2013 San Antonio Breast Cancer Symposium, alongside other explore that investigated ways to improve treatment for women with HER2-positive breast cancer. This aggressive form of cancer is linked to a genetic irregularity. Other researchers reported the following. The targeted dull trastuzumab (Herceptin) worked better in HER2-positive breast cancer tumors containing high levels of immune cells.

A combination of the chemotherapy drugs docetaxel and carboplatin with Herceptin appeared to be the best postsurgery healing option. Overall, the studies were good news for women with HER2-positive breast cancer, which used to be one of the most fatal forms of the disease. Researchers reported long-term survival rates higher than 90 percent for women treated using the targeted remedy drugs. “That tells you these treatments are very, very effective,” Piccart-Gebhart said.

Piccart-Gebhart’s combo targeted psychoanalysis trial is evaluating whether the HER2-targeted drugs Herceptin and lapatinib (Tykerb) work better when combined on top of standard chemotherapy. The trial involved 455 patients with HER2-positive core cancer with tumors larger than 2 centimeters. The women were given chemotherapy prior to surgery along with either Herceptin, Tykerb, or a combination of the two targeted drugs. They also were treated after surgery with whichever targeted psychotherapy they had been receiving.

Parts: 1 2 3

Amphotericin B And Flucytosine For Antifungal Therapy. Part 3 of 3

Posted on by TraciKaufman

Amphotericin B And Flucytosine For Antifungal Therapy – Part 3 of 3

The current study included 299 people with cryptococcal meningitis who were randomly assigned to one of three treatment regimens: amphotericin B just for four weeks; amphotericin B plus flucytosine for two weeks; or amphotericin B plus fluconazole for two weeks. People in the second and third groups were also given eight weeks of reinforcement therapy with fluconazole. The investigators found that combination therapy with amphotericin B and flucytosine resulted in a 40 percent lower risk of death compared to amphotericin therapy alone.

Combination cure with fluconazole didn’t appear to affect survival rates, according to the study. The combination therapy with flucytosine also resulted in lower levels of Cryptococcus in the spinal fluid, according to the study. Side paraphernalia were similar in all three treatment regimens. Possible side effects are anemia, low levels of potassium, low white blood cell counts and additional infections, the study authors noted.

This observe is the first ever to demonstrate that a combination of antifungal drugs can significantly reduce the risk of death from this disease,” Day pointed out. The reason for the success of this particular combination is that it on the double kills Cryptococcus, according to the author of an accompanying editorial, Dr John Perfect, of Duke University Medical Center in Durham, NC “In cryptococcal meningitis, the principle is set: the high-speed killing of yeasts at the site of infection translates into a better outcome. Long-term success in the treatment of cryptococcal meningitis depends on how well we kill yeasts with the initial treatment regimen niconot. The study, which was funded by the Wellcome Trust and the British Infection Society, is published in the April, 4 2013 edition of the New England Journal of Medicine.

Parts: 1 2 3

Amphotericin B And Flucytosine For Antifungal Therapy. Part 2 of 3

Posted on by TraciKaufman

Amphotericin B And Flucytosine For Antifungal Therapy – Part 2 of 3

But, Hirsch eminent that this infection is unusual to see in the United States. That’s definitely not the case in the rest of the world. There are about 1 million cases of cryptococcal meningitis worldwide each year, and 625000 deaths associated with those infections, according to go into background information. Meningitis is an infection of the meninges, the protective membranes that cover the brain and the spinal cord.

infection

Meningitis can be caused by bacteria, viruses and fungi, according to the US Centers for Disease Control and Prevention. Cryptococcal meningitis is caused by the fungus Cryptococcus. There are 30 strains of Cryptococcus, and one that often causes infection is Cryptococcus neoformans. “Most of us have been exposed to Cryptococcus neoformans.

It is ubiquitous in the environment, associated with trees, bird guano and soil. Infection is kind-heartedness to occur from the inhalation of spores”. People can be infected for years without knowing it, according to Day. But, if someone who’s infected has weakened immunity, the infection can then creation to wreak havoc. Common ways people become immune-suppressed are through an HIV infection, taking immune-suppressing medications for organ transplantation, or taking immune-system altering medications for long-standing inflammatory diseases.

Parts: 1 2 3

Amphotericin B And Flucytosine For Antifungal Therapy. Part 1 of 3

Posted on by TraciKaufman

Amphotericin B And Flucytosine For Antifungal Therapy – Part 1 of 3

Amphotericin B And Flucytosine For Antifungal Therapy. A numb regimen containing two powerful antifungal medicines – amphotericin B and flucytosine – reduced the endanger of dying from cryptococcal meningitis by 40 percent compared to treatment with amphotericin B alone, according to new research in April 2013. The study also found that those who survived the sickness were less likely to be disabled if they received treatment that included flucytosine. “Combination antifungal therapy with amphotericin and flucytosine for HIV-associated cryptococcal meningitis significantly reduces the risk of dying from this disease,” said the study’s chief author, Dr Jeremy Day, head of the CNS-HIV Infections Group for the Wellcome Trust Major Overseas Program in Vietnam. “This combination could save 250000 deaths across Africa and Asia each year.

The legend to achieving this will be improving access to the antifungal agent flucytosine,” said Day, also a research lecturer at the University of Oxford. Flucytosine is more than 50 years enduring and off patent, according to Day. The drug has few manufacturers, and it isn’t licensed for use in many of the countries where the burden from this disease is highest.

Where it is available, the limited supply often drives the cost higher. “We count the results of this study will help drive increased and affordable access to both amphotericin and flucytosine. Infectious disease specialist Dr Bruce Hirsch, an attending physician at North Shore University Hospital in Manhasset, NY, said that in the United States, “the use of these medicines, amphotericin and flucytosine, is the usual prevailing of care for this dangerous infection, and is followed by long-term treatment with fluconazole another antifungal”.

Parts: 1 2 3

Preparation For Colonoscopy As A Tablet Relieves Suffering From The Procedure. Part 3 of 3

Posted on by TraciKaufman

Preparation For Colonoscopy As A Tablet Relieves Suffering From The Procedure – Part 3 of 3

How to Prepare for the Test. You will trouble to completely cleanse the bowel. Your health care provider will give you instructions for doing this. This may include a combination of enemas, not eating swarming foods for 2 or 3 days before the test, and taking laxatives. You will usually be told to stop taking aspirin, ibuprofen, naproxen, or other blood-thinning medications for several days before the test.

You will be asked to drink plenteousness of clear liquids for 1 – 3 days before the test. Examples of clear liquids are: fat-free bouillon or broth, water, clean coffee or tea, strained fruit juices, sports drinks, and gelatin. Unless otherwise instructed, on taking any regularly prescribed medication.

Stop taking iron preparations a few weeks before the test, unless otherwise instructed by your health care provider. Iron residues show a dark black stool, which makes the view inside the bowel less clear. People with some heart valve diseases may receive antibiotics before and after the test to prevent infection. Outpatients must layout to have someone take them home after the test, because they will be woozy and unable to drive.

Parts: 1 2 3